Osaka, Japan

Yuji Obata

This inventor holds 1 USPTO granted patent. Top assignee: Kanebo, Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuji Obata. Retrieved from https://idiyas.com/inventor/yuji-obata-pjqrbpdx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuji Obata: Innovator in Pharmaceuticals from Osaka

Introduction

Yuji Obata is an accomplished inventor based in Osaka, Japan. He is known for his contributions to the field of pharmaceuticals, specifically through his innovative patent related to acylphenylglycine derivatives.

Latest Patents

Yuji Obata holds a notable patent for an acylphenylglycine derivative. This invention plays a crucial role as a preventive and remedy for various diseases, showcasing his dedication to advancing medical science and improving healthcare outcomes.

Career Highlights

Currently, Yuji Obata works at Kanebo, Limited, a prominent company in the pharmaceutical sector. His position there allows him to leverage his expertise in research and development to create impactful solutions for health-related challenges.

Collaborations

Throughout his career, Yuji has collaborated with several talented individuals, including coworkers Ryoichi Hirayama and Takahiro Tsukida. These partnerships have further enhanced his inventive capabilities and fostered an environment of innovation within his team.

Conclusion

Yuji Obata is a remarkable inventor whose work continues to influence the field of pharmaceuticals. With his patent on acylphenylglycine derivatives, he is making strides in developing preventative and therapeutic solutions, underscoring the important role that inventors play in advancing medical science. His affiliation with Kanebo, Limited further strengthens his impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…